Thrombocytopenia secondary to platelet consumption during disseminated intravascular coagulation (DIC) is observed in critically ill cancer patients, however, the classic changes of DIC—fibrinogen consumption and several fold‐prolongation of prothrombin time—were not seen in our cohort. The gene discussed is F2; the disease is Thrombocytopenia.